期刊文献+

哌仑西平脂质体在家兔眼内的药代动力学研究 被引量:1

Pharmacokinetics of pirenzepine liposome in the rabbit eyes
在线阅读 下载PDF
导出
摘要 目的研究哌仑西平脂质体结膜囊内应用后在家兔眼部的药代动力学。方法48只家兔随机分为磷酸盐缓冲液组和脂质体组,分别于给药后0.5、1、2、4、6、8、10、12h取材,采用高压液相色谱技术进行测定,3P97软件拟合药代动力学参数,统计学分析采用t检验和单因素方差分析。结果脂质体组各组织中哌仑西平的质量浓度和质量分数较磷酸缓冲液组高,用药2h后各时间点各组织间相比均有显著统计学差异(P<0.01),它们在各组织中的变化均呈一室开放模型。同一种组织中除脉络膜的消除半衰期外,其余组织各药代动力学参数间(Cmax、t1/2、MRT、AUC)差异有统计学意义(P<0.05)。巩膜中哌仑西平的质量分数高于脉络膜和视网膜(P<0.05)。结论哌仑西平脂质体眼部应用有缓释效应,生物利用度高,其很可能是以非角膜途径吸收为主进入眼内的。 Objective We have report the preparation of pirenzepine liposome in previous paper. The purpose of this study is to investigate the pharmacokinetics of pircnzcpine in various tissues of rabbit eyes after topical application of pirenzepine liposome. Methods Forty-eight New-Zealand rabbits were randomly divided into pirenzepine phosphoric acid buffer and pirenzepine liposome group and then subdivided into 8 groups according to the different scarifying time in both groups respectively. 0.3% pirenzepine phosphoric acid buffer and 0.3% pirenzepine liposome were topically applied in both eyes of each rabbit respectively. The levels of pirenzepine in aqueous humor, vitreous body, retina, ehoroids and selera were examined at 0.5, 1 hour, 2, 4, 6, 8, 10 and 12 hours after topical application of two drugs by high performance liquid chromatography with imipramine as an internal standard. All the pharmaeokinetie parameters in the same tissue after application of two drugs were compared, and the concentration of pirenzepine in the retina, ehoroid and selera were analyzed. Results The concentration of pirenzepine in aqueous humor, vitreous body, retina, ehoroid and selera was higher in pirenzepine liposome group than that in pirenzepine phosphoric acid buffer group 2 hours later with a significant difference between two groups (P 〈 0.01). The concentration of pirenzepine in all the ocular tissues was subjected to one-compartment open model after topical application of two drugs. All the pharmacokinetic parameters in the same tissue, including Cmax, t1/2. MRT, and AUC, exhibited statistically significant difference (P 〈 0.05) except for the t1/2 in choroids (P 〉 0.05) between two groups. The pirenzepine concentration in sclera was higher than that in retina and choroids (P 〈 0.05). Conclusion The sustained release of pirenzepine liposome and its bioavailability are higher of than that pirenzepine phosphoric acid buffer followed the topical administration in rabbit eyes. These drugs may enter into the intraocular tissue mainly by the non-cornea pathway after topical application.
出处 《眼科研究》 CSCD 北大核心 2006年第2期132-135,共4页 Chinese Ophthalmic Research
关键词 哌仑西平 脂质体 药代动力学 pirenzepine liposome pharmacokinetics eyes
  • 相关文献

参考文献11

  • 1戴怡康,褚仁远.哌仑西平滴眼剂在兔房水中的药代动力学研究[J].眼视光学杂志,2002,4(4):228-229. 被引量:11
  • 2戴淑真,曾骏文,王子亮,吴昌凡.哌仑西平脂质体的研制及评价[J].中山大学学报(医学科学版),2004,25(3):217-220. 被引量:2
  • 3Cottriall CL,McBrien NA,Annies R,et al.Prevention of form-deprivation myopia with pirenzepine:a study of drug delivery and distribution[J].Ophthalmic Physiol Opt,1999,19(4):327-335
  • 4Tanswell P,Kasper W,Zahn GJ.Automated monoclonal radioimmunoassays for pirenzepine,a selective muscarinic receptor antagonist,in plasma and urine[J].Immunol Methods,1986,93(2):247-258
  • 5Bobhair SA.Analysis of pirenzepine in plasma by high-performance liquid chromatography[J].J Liq Chromatogr,1984,7(10):2401-2403
  • 6Meineke I,Witsch D,Brendel E.Sensitive high performance liquid chromatographic determination of pirenzepine in plasma[J].J Chromatogr,1986,375(2):369-375
  • 7Chavez CM,Constanzer ML,Matuszewski BK.Determination of pirenzepine in human plasma using liquid chromatography with tandem mass spectrometric detection[J].J Pharm Biomed Anal,1995,13(9):1179-1184
  • 8Worakul N,Robinson JR.Ocular pharmacokinetics/pharmacodynamics[J].Eur J Pharma Biopharma,1997,44(1627):71-83
  • 9Bar-Ilan A.Basic considerations of ocular drug delivery systems.In:Zimmerman TJ,Kooner KS,Sharir M,et al.Eds.Textbook of ocular pharmacology[M].Philadelphia:Lippincott-Raven,1997.139-150
  • 10Wang W,Sasaki H,Chien DS,et al.Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit:a comparison with corneal penetration[J].Curr Eye Res,1991,10(6):571-579

二级参考文献21

  • 1Leech EM, Cottriall CL, McBrien NA. Pirenzepine prevents form deprivation myopia in a dose dependent manner[ J ]. Ophthalmic Physiol Opt,1995,15(5): 351-356
  • 2Tigges M, Iuvone PM, Fernandes A, et al. Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys[J]. Optom Vis Sci, 1999,76(6): 397 -407
  • 3Rickers M,Schaeffel F. Dose-dependent effects of intravitreal pirenzepine on deprivation myopia and lens-induced refractive errors in chickens [ J ].Exp Eye Res, 1995,61 ( 4 ): 509 - 516
  • 4Christensen AM, Wallman J. Evidence that increased scleral growth underlies visual deprivation myopia in chicks[ J]. Invest Ophthalmol Vis Sci,1991,32(7): 2143 -2150
  • 5Lind GJ, Chew SJ, Marzani D, et al. Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes[ J ]. Invest Ophthalmol Vis Sci,1998,39(12): 2217-2231
  • 6Cha YL,Weon SR, Beuerman RW. Effect of muscarinic agents and the role of sclera fibroblasts in experimental myopia [ J ]. Invest Ophthalmol Vis Sci,2002,43:S411
  • 7Kusakari T,Sato T,Tokoro T. Visual deprivation stimulates the exchange of the fibrous sclera into the cartilaginous sclera in chicks [ J ]. Exp Eye Res,2001,73 (4): 533 - 546
  • 8Stone RA, Lin T, Laties AM. Muscarinic antagonist effects on experimental chick myopia[ J ]. Exp Eye Res, 1991,52 (6): 755 - 758
  • 9Cottriall CL, McBrien NA. The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew [ J ]. Invest Ophthalmol Vis Sci, 1996,37 ( 7 ): 1368 - 1379
  • 10Cottriall CL, McBrien N A, Annies R, et al. Prevention of form-deprivation myopia with pirenzepine: a study of drug delivery and distribution [ J ].Ophthalmic Physiol Opt, 1999,19 (4): 327 - 335

共引文献12

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部